Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
Ana Cecilia Ulloa, Sarah A. Buchan, Nick Daneman, et al.
JAMA (2022) Vol. 327, Iss. 13, pp. 1286-1286
Open Access | Times Cited: 282

Showing 1-25 of 282 citing articles:

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg, Neil M. Ferguson, Sophie Nash, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1303-1312
Open Access | Times Cited: 1150
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 471
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 406
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1933-1943
Open Access | Times Cited: 321
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
Carlos King Ho Wong, Ivan Chi Ho Au, Kristy T. K. Lau, et al.
The Lancet (2022) Vol. 400, Iss. 10359, pp. 1213-1222
Open Access | Times Cited: 243
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Samir Bhatt, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 967-976
Open Access | Times Cited: 178
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 138
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 132
COVID-19 will continue but the end of the pandemic is near
Christopher J L Murray
The Lancet (2022) Vol. 399, Iss. 10323, pp. 417-419
Open Access | Times Cited: 106
Nanotechnology-based strategies against SARS-CoV-2 variants
Xiangang Huang, Edo Kon, Xuexiang Han, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 10, pp. 1027-1037
Open Access | Times Cited: 102
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
Da‐Yuan Chen, Chue Vin Chin, Devin Kenney, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 143-150
Open Access | Times Cited: 94
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
Ryuta Uraki, Peter Halfmann, Shun Iida, et al.
Nature (2022) Vol. 612, Iss. 7940, pp. 540-545
Open Access | Times Cited: 87
Clinical outcomes associated with Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 81
Population-based evaluation of the effectiveness of nirmatrelvir–ritonavir for reducing hospital admissions and mortality from COVID-19
Kevin L. Schwartz, Jun Wang, Mina Tadrous, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 6, pp. E220-E226
Open Access | Times Cited: 78
The end of the COVID‐19 pandemic
John P. A. Ioannidis
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 6
Open Access | Times Cited: 69
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England
Zachary H. Strasser, Noah Greifer, Aboozar Hadavand, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2238354-e2238354
Open Access | Times Cited: 69
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Severity of the Omicron SARS‐CoV‐2 variant compared with the previous lineages: A systematic review
Maryam Arabi, Yousef Al‐Najjar, Nada Mhaimeed, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 11, pp. 1443-1464
Open Access | Times Cited: 51
Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients
Benoît Misset, Michaël Piagnerelli, Eric A. J. Hoste, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 17, pp. 1590-1600
Open Access | Times Cited: 48
Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry
Guillaume Favre, Émeline Maisonneuve, Léo Pomar, et al.
The Lancet Regional Health - Europe (2023) Vol. 26, pp. 100569-100569
Open Access | Times Cited: 39
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 63
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study
Vincent Auvigne, Sophie Vaux, Yann Le Strat, et al.
EClinicalMedicine (2022) Vol. 48, pp. 101455-101455
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top